European Journal of Surgical Oncology
Volume 32, Issue 10 , Pages 1101-1104 , December 2006

Radioactivity thresholds for sentinel node biopsy in breast cancer

  • S. Morota

      Affiliations

    • Department of Nuclear Medicine, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • Department of Breast Surgery, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • M. Koizumi

      Affiliations

    • Department of Nuclear Medicine, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 3 3570 0205; fax: +81 3 3570 0204.
    • ,
  • M. Koyama

      Affiliations

    • Department of Nuclear Medicine, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • T. Sugihara

      Affiliations

    • Department of Nuclear Medicine, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • Department of Breast Surgery, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • K.-I. Tada

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • Y. Miyagi

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • S.-I. Nishimura

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • M. Makita

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • T. Iwase

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • M. Yoshimoto

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • F. Kasumi

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan

,Accepted 6 March 2006.

References 

  1. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. N Engl J Med. 1998;339:941–946
  2. Borgstein PJ, Meijer S, Pijpers RJ, van Diest PJ. Functional lymphatic anatomy for sentinel node biopsy in breast cancer. Ann Surg. 2000;232:81–89
  3. Veronessi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. New Engl J Med. 2003;349:546–553
  4. Edge SB, Niland JC, Bookman MA, et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst. 2003;95:1514–1521
  5. Martin RCG, Fey J, Yeung H, Borgen PI, Cody HS. Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol. 2001;8:592–597
  6. Camp ER, Cendan JC, Feezon R, Lind DS, Wilkinson E, Copeland EM. The hottest sentinel lymph node is not always the positive node. Am Surg. 2004;70:475–478
  7. Martin RCG, Edwards MJ, Wong SL, et al. Practical guidelines of optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of multi-institutional study. Surgery. 2000;128:139–144
  8. McMaster KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560–2566
  9. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001;42:1198–1215
  10. Koizumi M, Nomura E, Yamada Y, et al. Sentinel node detection using Tc-99m rhenium sulfide colloid in patients with breast cancer: 1-day and 2-day protocols with dose finding study. Nucl Med Commun. 2003;24:663–670
  11. Koizumi M, Nomura E, Yamada Y, et al. Radio-guided sentinel node detection in breast cancer patients: comparison between Tc-99m phytate and Tc-99m rhenium colloid. Nucl Med Commun. 2004;25:1031–1037
  12. Bourgeois P, Nogaret JM, Veys I, et al. How ‘hot’ is the pathologically positive sentinel lymph node in breast cancer patients?. Nucl Med Commun. 2003;24:513–518
  13. Dowlatshahi K, Fan M, Anderson JM, Bloom KJ. Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol. 2001;8:675–682
  14. Duncan M, Cech A, Wechter D, Moonka R. Criteria for establishing the adequacy of a sentinel lymphadenectomy. Am J Surg. 2004;187:639–642
  15. McCarter MD, Yeung H, Fey J, Borgen PI, Cody HS. The breast cancer patient with multiple sentinel nodes: when to stop?. J Am Coll Surg. 2001;192:692–697
  16. Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001;192:684–691
  17. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med. 2005;35:116–128

PII: S0748-7983(06)00112-0

doi: 10.1016/j.ejso.2006.03.017

European Journal of Surgical Oncology
Volume 32, Issue 10 , Pages 1101-1104 , December 2006

Article Tools